Valion Bio (VBIO) Other Operating Expenses (2021 - 2025)

Valion Bio (VBIO) posted quarterly Other Operating Expenses of -$117000.0 for Q3 2025, down 117.86% quarter-over-quarter from $655000.0 in Q2 2025.

Valion Bio (VBIO) Other Operating Expenses (2021 - 2025) Analysis & Trends

Valion Bio's Other Operating Expenses history runs 5 years deep, the most recent figure standing at -$117000.0 for Q3 2025.

In Q3 2025, Other Operating Expenses changed N/A year-over-year to -$117000.0; the TTM figure through Dec 2025 stood at $873000.0 (up 5.18% YoY), while the FY2024 annual figure was $1.3 million, down 38.21% from the prior year.
Other Operating Expenses for Q3 2025 stood at -$117000.0, down from $655000.0 in the prior quarter.
The five-year high for Other Operating Expenses was $1.1 million in Q2 2022, with the low at -$217000.0 in Q4 2021.
The 5-year median for Other Operating Expenses is $424500.0 (2021), against an average of $404333.3.
The sharpest annual moves came in 2022 and 2023: Other Operating Expenses soared 485.94% in 2022, then tumbled 58.4% in 2023.
Valion Bio's Other Operating Expenses stood at -$217000.0 in 2021, then surged by 330.88% to $501000.0 in 2022, then soared by 46.71% to $735000.0 in 2023, then sank by 50.07% to $367000.0 in 2024, then sank by 131.88% to -$117000.0 in 2025.
Business Quant data shows VBIO's Other Operating Expenses at -$117000.0 in Q3 2025, $655000.0 in Q2 2025, and $335000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.40 Bn	131.54 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.13 Bn	78.13 Bn	3.93 Bn
3	Argenx Se	65.58 Bn	60.40 Bn	1.37 Bn
4	Moderna	58.23 Bn	53.09 Bn	52.00 Mn
5	BeOne Medicines	42.18 Bn	37.08 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.61 Bn	28.30 Bn	992.69 Mn
7	BioNTech SE	27.97 Bn	9.58 Bn	668.28 Mn
8	Insmed	27.55 Bn	26.39 Bn	358.27 Mn
9	Royalty Pharma	27.31 Bn	26.47 Bn	-
10	Valion Bio	408,979.63	-1.79 Mn	-45,000.00

Download Data